INSM Competitors & Alternatives
Compare Insmed Inc with similar stocks in the same industry
Biotechnology
INSM
Main Stock$120.75
Tradestie Score
37
Market Cap
$31.13B
Revenue Growth
2.7%
Analyst Upside
+60.8%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$419.98
|
$36.81B | 54.4 | 35 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$87.65
|
$24.57B | - | 62 | Compare |
|
NTRA
Natera, Inc. Common Stock
|
$319.82
|
$22.18B | - | 65 | Compare |
|
GMAB
Genmab A/S ADS
|
$53.87
|
$19.56B | 46.2 | 33 | Compare |
|
INCY
Incyte Genomics Inc
|
$122.27
|
$16.93B | 61.4 | 52 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$70.01
|
$15.70B | 45.4 | 36 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.64
|
$15.22B | - | 42 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$259.28
|
$12.36B | 19.7 | 34 | Compare |
|
EXEL
Exelixis Inc
|
$70.70
|
$11.09B | 21.1 | 23 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$41.85
|
$10.76B | - | 42 | Compare |
More INSM Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry